CONCERT PHARMACEUTICALS INC's ticker is CNCE and the CUSIP is 206022105. A total of 55 filers reported holding CONCERT PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.49 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $342,218 | -33.5% | 58,599 | -23.7% | 0.27% | -37.9% |
Q3 2022 | $515,000 | +60.4% | 76,801 | +0.6% | 0.43% | +58.0% |
Q2 2022 | $321,000 | +23.9% | 76,354 | -0.5% | 0.27% | +60.2% |
Q1 2022 | $259,000 | -3.7% | 76,749 | -10.2% | 0.17% | +8.9% |
Q4 2021 | $269,000 | -24.4% | 85,483 | +1.3% | 0.16% | -35.7% |
Q2 2021 | $356,000 | -13.4% | 84,368 | +2.4% | 0.24% | -21.0% |
Q1 2021 | $411,000 | -57.0% | 82,402 | +9.1% | 0.31% | -60.8% |
Q4 2020 | $955,000 | – | 75,533 | – | 0.79% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Kynam Capital Management, LP | 4,420,349 | $25,814,838 | 3.96% |
Parkman Healthcare Partners LLC | 1,203,484 | $7,028,347 | 1.87% |
SPHERA FUNDS MANAGEMENT LTD. | 1,002,783 | $5,856,253 | 1.26% |
TANG CAPITAL MANAGEMENT LLC | 1,150,000 | $6,716,000 | 0.98% |
BVF INC/IL | 3,629,000 | $21,193,360 | 0.89% |
Nantahala Capital Management | 1,732,388 | $10,117,146 | 0.66% |
AWM Investment Company, Inc. | 666,661 | $3,893,300 | 0.56% |
INGALLS & SNYDER LLC | 1,295,833 | $7,568 | 0.41% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 200,800 | $1,172,672 | 0.36% |
Kensington Investment Counsel, LLC | 58,599 | $342,218 | 0.27% |